Wego Intervention Receives Ukrainian Medical Device Registration Certificate for Its Self-Developed Metallic Drug-Eluting Stent System
Kinhely
Cardiovascular Interventional Device R&D and Production Company
Recently, the metal drug-eluting stent system independently developed by Shenzhen Kinhely Bio-Tech Co., Ltd., a subsidiary of Weigao Interventional Group, passed the review by Ukrainian regulatory authorities and obtained the Ukrainian medical device registration certificate, marking that its products have officially gained market access qualifications in Eastern Europe.
Weigao Interventional consistently adheres to the core philosophy of innovation-driven development and strictly complies with international quality standards. This certification not only concretely demonstrates the company’s comprehensive capabilities in research and development, manufacturing, and compliance management, but also reaffirms its steadfast commitment to serving patients worldwide.
In the future, Weigao Interventional will continue to deepen its presence in international markets, increase R&D investment, and enhance product quality, serving global patients with superior and safer products, thereby laying a solid foundation for Chinese-made medical devices to expand overseas and establish a strong foothold in the global market.
